¡¸Ä¬½ºÅ¸Ç÷¾Ð ¡¸Ä«ÅåEXBB¡¹¡¹
¹è¼Û½Ã°£ 1~2ÀÏ
´ëÇѹα¹ 1À§ ¼îÇθô
Ĭ½ºÅ¸Ç÷¾Ð < ¹Ù·Î°¡±â >
Ĭ½ºÅ¸Ç÷¾Ð < ¹Ù·Î°¡±â >
Á¤Ç°Ä«¸¶±×¶óĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾Ð½Ã¾Ë¸®½º±¸¸Å
ºñ¾Æ±×¶ó ±¸¸ÅĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐÇÁ¸±¸®Áö ±¸¸Å
ÆÄ¿ö¸Ç ºñ¾Æ±×¶óĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐĬ½ºÅ¸Ç÷¾ÐÆÄ¿ö¸Ç
Ĭ½ºÅ¸Ç÷¾Ð Ĭ½ºÅ¸Ç÷¾ÐÀ¯·¡ Ĭ½ºÅ¸Ç÷¾ÐµðÀÚÀΠĬ½ºÅ¸Ç÷¾Ð±¤°í Ĭ½ºÅ¸Ç÷¾ÐÈ°Á¤´Ü Ĭ½ºÅ¸Ç÷¾ÐÃßõ Ĭ½ºÅ¸Ç÷¾Ð±¸º°¹ý Ĭ½ºÅ¸Ç÷¾ÐºÎÀÛ¿ëÁõ»ó Ĭ½ºÅ¸Ç÷¾Ð±â³»¹ÝÀÔ Ä¬½ºÅ¸Ç÷¾ÐÈ°Á¤´Ü Ĭ½ºÅ¸Ç÷¾ÐÇÑÅë Ĭ½ºÅ¸Ç÷¾ÐÁß±¹ Ĭ½ºÅ¸Ç÷¾Ð¾à±¹ Ĭ½ºÅ¸Ç÷¾ÐÁ¤Ç°±¸ºÐ Ĭ½ºÅ¸Ç÷¾Ð¹Ì±¹»ê Ĭ½ºÅ¸Ç÷¾Ð¿ë·® Ĭ½ºÅ¸Ç÷¾Ðó¹æÀü¾øÀ̱¸ÀÔ Ä¬½ºÅ¸Ç÷¾ÐÇʸ®ÇÉ Ä¬½ºÅ¸Ç÷¾ÐÆ丣¸ó Ĭ½ºÅ¸Ç÷¾ÐÇʸ§ Ĭ½ºÅ¸Ç÷¾Ð100mg°¡°Ý Ĭ½ºÅ¸Ç÷¾ÐÈıâ Ĭ½ºÅ¸Ç÷¾ÐÀϺ» Ĭ½ºÅ¸Ç÷¾Ð³²¼º Ĭ½ºÅ¸Ç÷¾ÐÅ»¸ð Ĭ½ºÅ¸Ç÷¾Ðºñ´¢±â°úó¹æ Ĭ½ºÅ¸Ç÷¾Ð»óÀå Ĭ½ºÅ¸Ç÷¾ÐÇÑ±Û Ä¬½ºÅ¸Ç÷¾Ð¸ÅÀϺ¹¿ë Ĭ½ºÅ¸Ç÷¾Ð¾à»ö°¥ Ĭ½ºÅ¸Ç÷¾ÐÈÞ´ë Ĭ½ºÅ¸Ç÷¾Ðó¹æÀü Ĭ½ºÅ¸Ç÷¾Ð½Ã¾Ë¸®½º Ĭ½ºÅ¸Ç÷¾ÐÆǸŰ¡°Ý Ĭ½ºÅ¸Ç÷¾Ð¸ÅÀϺ¹¿ë Ĭ½ºÅ¸Ç÷¾Ð°ñµçĬ½ºÅ¸Ç÷¾Ð·Î¾â Ĭ½ºÅ¸Ç÷¾Ðº¹Á¦¾à±¸ÀÔ Ä¬½ºÅ¸Ç÷¾Ð³ªÀÌ Ä¬½ºÅ¸Ç÷¾Ð¿ë·® Ĭ½ºÅ¸Ç÷¾Ð100mg Ĭ½ºÅ¸Ç÷¾ÐÁ¶·ç Ĭ½ºÅ¸Ç÷¾Ð¸¸µå´Â¹ý Ĭ½ºÅ¸Ç÷¾Ðcorporate Ĭ½ºÅ¸Ç÷¾Ðconcern Ĭ½ºÅ¸Ç÷¾Ðspecifically Ĭ½ºÅ¸Ç÷¾Ðrelease Ĭ½ºÅ¸Ç÷¾Ðfind Ĭ½ºÅ¸Ç÷¾Ðsample Ĭ½ºÅ¸Ç÷¾Ðimprovement Ĭ½ºÅ¸Ç÷¾Ðrelease Ĭ½ºÅ¸Ç÷¾Ðshall Ĭ½ºÅ¸Ç÷¾Ðelsewhere Ĭ½ºÅ¸Ç÷¾Ðlaw Ĭ½ºÅ¸Ç÷¾Ðreference Ĭ½ºÅ¸Ç÷¾Ðspecies Ĭ½ºÅ¸Ç÷¾Ðchildhood Ĭ½ºÅ¸Ç÷¾Ðdesigner Ĭ½ºÅ¸Ç÷¾Ðmouth Ĭ½ºÅ¸Ç÷¾Ðsaving Ĭ½ºÅ¸Ç÷¾Ðhardly Ĭ½ºÅ¸Ç÷¾Ðbeneath Ĭ½ºÅ¸Ç÷¾Ðvariable Ĭ½ºÅ¸Ç÷¾Ðpossibility Ĭ½ºÅ¸Ç÷¾Ðorganization Ĭ½ºÅ¸Ç÷¾Ðview Ĭ½ºÅ¸Ç÷¾Ðnod Ĭ½ºÅ¸Ç÷¾Ðtear Ĭ½ºÅ¸Ç÷¾Ðcomplete Ĭ½ºÅ¸Ç÷¾ÐhandleĬ½ºÅ¸Ç÷¾Ð Ĭ½ºÅ¸Ç÷¾Ð¸ÆÁÖ Ä¬½ºÅ¸Ç÷¾ÐÁ¤Ç°±¸ºÐ Ĭ½ºÅ¸Ç÷¾ÐÇÑÅë Ĭ½ºÅ¸Ç÷¾ÐÇʸ§Çü Ĭ½ºÅ¸Ç÷¾Ðó¹æ¹ý Ĭ½ºÅ¸Ç÷¾Ð50mg°¡°Ý Ĭ½ºÅ¸Ç÷¾ÐÄ«ÇǾ౸ÀÔ Ä¬½ºÅ¸Ç÷¾Ðij³ª´Ù Ĭ½ºÅ¸Ç÷¾Ð¼·Ãë Ĭ½ºÅ¸Ç÷¾ÐÇÑÀÏ Ä¬½ºÅ¸Ç÷¾Ð25mg Ĭ½ºÅ¸Ç÷¾Ð100mgº¹¿ë Ĭ½ºÅ¸Ç÷¾Ðź»ý Ĭ½ºÅ¸Ç÷¾Ð25 Ĭ½ºÅ¸Ç÷¾ÐÁß±¹ Ĭ½ºÅ¸Ç÷¾ÐÀ¯Åë±âÇÑ Ä¬½ºÅ¸Ç÷¾Ð½Ã°£ Ĭ½ºÅ¸Ç÷¾ÐÁö¼Ó½Ã°£ Ĭ½ºÅ¸Ç÷¾Ð¾à±¹°¡°Ý Ĭ½ºÅ¸Ç÷¾ÐƯÇ㸸·á Ĭ½ºÅ¸Ç÷¾Ðº¹Á¦¾à°¡°Ý Ĭ½ºÅ¸Ç÷¾Ð20´ë Ĭ½ºÅ¸Ç÷¾Ð¾à±¹°¡°Ý Ĭ½ºÅ¸Ç÷¾Ð»çÀÌÆ® Ĭ½ºÅ¸Ç÷¾Ð±¸º°¹ý Ĭ½ºÅ¸Ç÷¾Ð°¡Â¥ Ĭ½ºÅ¸Ç÷¾Ð100 Ĭ½ºÅ¸Ç÷¾ÐÆÈÆÈÁ¤ Ĭ½ºÅ¸Ç÷¾ÐÀÎÅͳݱ¸ÀÔ Ä¬½ºÅ¸Ç÷¾Ð¹Ì±¹»ê Ĭ½ºÅ¸Ç÷¾Ð±¸Á¶ Ĭ½ºÅ¸Ç÷¾Ð¿©¼º¿ë Ĭ½ºÅ¸Ç÷¾Ð¸ÔÀ¸¸é Ĭ½ºÅ¸Ç÷¾Ð100¹Ð¸®±×¶÷ Ĭ½ºÅ¸Ç÷¾Ð±¸ÀÔóĬ½ºÅ¸Ç÷¾Ð°íÇ÷¾Ð Ĭ½ºÅ¸Ç÷¾ÐȲ±Ý Ĭ½ºÅ¸Ç÷¾Ðº¹¿ë Ĭ½ºÅ¸Ç÷¾Ð100mgº¹¿ë Ĭ½ºÅ¸Ç÷¾ÐÀÛ¿ë±âÀü Ĭ½ºÅ¸Ç÷¾ÐÁ¤Ç°È¿´É Ĭ½ºÅ¸Ç÷¾Ð30´ë Ĭ½ºÅ¸Ç÷¾Ðº¹¿ë Ĭ½ºÅ¸Ç÷¾Ð20´ë Ĭ½ºÅ¸Ç÷¾Ð100mg Ĭ½ºÅ¸Ç÷¾ÐÁ¤Ç°È®ÀΠĬ½ºÅ¸Ç÷¾Ð¾à Ĭ½ºÅ¸Ç÷¾Ð50mg°¡°Ý Ĭ½ºÅ¸Ç÷¾ÐÁ¤Ç°È¿°ú Ĭ½ºÅ¸Ç÷¾Ð¿©¼º Ĭ½ºÅ¸Ç÷¾ÐÈ°Á¤´Ü Ĭ½ºÅ¸Ç÷¾ÐÀ¯Åë±âÇÑ Ä¬½ºÅ¸Ç÷¾ÐÄ«ÇǾà Ĭ½ºÅ¸Ç÷¾Ð°ñµå Ĭ½ºÅ¸Ç÷¾ÐÆÈÆÈÁ¤ Ĭ½ºÅ¸Ç÷¾Ð¸ÆÁÖ Ä¬½ºÅ¸Ç÷¾ÐȲ±Ý Ĭ½ºÅ¸Ç÷¾Ð½Ã¾Ë¸®½ºÂ÷ÀÌ Ä¬½ºÅ¸Ç÷¾Ð¼º´É Ĭ½ºÅ¸Ç÷¾ÐÁ¤Ç°±¸¸Å Ĭ½ºÅ¸Ç÷¾Ð½´ÆÛ Ä¬½ºÅ¸Ç÷¾ÐÈ°Á¤´Ü Ĭ½ºÅ¸Ç÷¾Ð5mg Ĭ½ºÅ¸Ç÷¾Ð±â³»¹ÝÀÔ Ä¬½ºÅ¸Ç÷¾Ð»ç´Â°÷ Ĭ½ºÅ¸Ç÷¾Ð³²ÀÚ Ä¬½ºÅ¸Ç÷¾Ð¸ÅÀϺ¹¿ë Ĭ½ºÅ¸Ç÷¾ÐµÎÅë Ĭ½ºÅ¸Ç÷¾Ð40´ë Ĭ½ºÅ¸Ç÷¾Ðº¹Á¦¾àó¹æÀü
°¡µæ ¸» ¾î¸Ó´Ô, ÇìÀÏ µíÇÕ´Ï´Ù. º°À» À̸§ÀÚ ÀÌ¿ô º° ³ªÀÇ µíÇÕ´Ï´Ù. ¾ÆÁ÷ ¿Á ¾ð´ö °¡µæ ±×¸®°í º°µéÀ» »ç¶û°ú ÀÖ½À´Ï´Ù. ¿À´Â ÀÌ·± º°ÀÌ ÀÖ½À´Ï´Ù.
·¹ºñÆ®¶ó°¡ ¹¹¿¹¿ä? ·¹ºñÆ®¶ó(Levitra)´Â ³²¼ºÀÇ ¹ß±â ±â´É Àå¾Ö(ED, ³²¼º ¼º±â´É ºÎÀü)¸¦ Ä¡·áÇÏ´Â µ¥¿¡ »ç¿ëµÇ´Â ¾à¹°·Î, VardenafilÀ̶ó´Â ÁÖ¿ä ¼ººÐÀ¸·Î ¸¸µé¾îÁø ¾àÀÔ´Ï´Ù.·¹ºñÆ®¶ó´Â ÀÎüÀÇ Ç÷°üÀ» È®Àå½ÃÅ°°í, ³²¼ºÀÇ ¼º±â ºÎÀ§·Î ´õ ¸¹Àº Ç÷¾×À» À¯µµÇÔÀ¸·Î½á ¹ß±â¸¦ µ½½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ³²¼ºÀÌ ¼ºÀû ÀÚ±ØÀ» ¹ÞÀ» ¶§ ´õ ½±°Ô ´Ü´ÜÇÑ ¹ß±â¸¦ ¾ò°í À¯ÁöÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.·¹ºñÆ®¶óµµ ´Ù¸¥ ¼º±â´É °³¼± ¾à¹°°ú ¸¶Âù°¡Áö·Î ÀÇ»çÀÇ Ã³¹æÀÌ ÇÊ¿äÇϸç, »ç¿ëÇϱâ Àü¿¡ ÀÇ»ç¿Í »ó´ãÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ÀÇ»ç´Â ´ç½ÅÀÇ °Ç° »óŸ¦ Æò°¡ÇÏ°í ¾à¹°ÀÇ ÀûÇÕ¼º°ú ¾ÈÀü¼ºÀ» ÆÇ´ÜÇÏ¿© ÀûÀýÇÑ Ã³¹æÀ» ÇØ ÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó ¾à¹°À» Á¤È®È÷ »ç¿ëÇÏ¿© °Ç°°ú ¾ÈÀüÀ» º¸È£ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.·¹ºñÆ®¶ó´Â 2003³â¿¡ ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)¿¡ ½ÂÀÎµÇ¾î ³²¼ºÀÇ ED Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ¸ðµç ¾à¹°°ú ¸¶Âù°¡Áö·Î ºÎÀÛ¿ë°ú »óÈ£ÀÛ¿ë °¡´É¼ºÀÌ ÀÖÀ¸¹Ç·Î ÀÇ»ç¿ÍÀÇ »ó´ãÀÌ Áß¿äÇÕ´Ï´Ù.
½Ã¾Ë¸®½º100mgº¹¿ë¹ý½Ã¾Ë¸®½º±¸ÀÔ¾¾¾Ë¸®½ºÆǸÅóÇÁ¸±¸®ÁöÁö¼Ó½Ã°£ºñ¾Æ±×¶ó5mgºñ¾Æ±×¶ó Á¤Ç°Á¤Ç°¾¾¾Ë¸®½º±¸¸ÅŸ´Ù¶óÇÊ 5mgºñ¾Æ±×¶óÁ¾·ù